Published on August 13, 2025
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that this Schedule 13G Amendment No. 4 dated August 13, 2025 relating to the Common Stock, $0.001 par value, of Sutro Biopharma, Inc. shall be filed on behalf of the undersigned.
SUVRETTA CAPITAL MANAGEMENT, LLC
By: /s/ Andrew Nathanson |
|
Name: Andrew Nathanson | |
Title: General Counsel and Chief Compliance Officer |
AVERILL MASTER FUND, LTD.
By: /s/ Andrew Nathanson |
|
Name: Andrew Nathanson | |
Title: Authorized Signatory |
AARON COWEN
By: /s/ Aaron Cowen |